We are live on
!
Find out more
IT
Independence Trust Portfolio holdings
AUM
$90.5M
1-Year Est. Return
24.37%
This Fund
S&P 500
This Quarter
Est. Return
-4.43%
1 Year Est. Return
+24.37%
3 Year Est. Return
+28.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$148M
AUM Growth
-$9.55M
(-6%)
Cap. Flow
-$1.67M
Cap. Flow
% of AUM
-1.12%
Top 10 Holdings %
Top 10 Hldgs %
49.65%
Holding
132
New
11
Increased
28
Reduced
43
Closed
13
Avg Time Held
5
quarters
Top 10 Avg Time Held
5.6
quarters
Top 20 Avg Time Held
5.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.28M |
| 2 |
NSL
NUVEEN SENIOR INCM FD
NSL
|
+$514K |
| 3 |
Eli Lilly
LLY
|
+$489K |
| 4 |
Manulife Financial
MFC
|
+$428K |
| 5 |
ING
ING
|
+$359K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$1.02M |
| 2 |
Blackstone Senior Floating Rate 2027 Term Fund
BSL
|
+$639K |
| 3 |
RAI
Reynolds American Inc
RAI
|
+$602K |
| 4 |
Royce Value Trust
RVT
|
+$548K |
| 5 |
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
|
+$505K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.77% |
| 2 | Healthcare | 10.5% |
| 3 | Industrials | 7.52% |
| 4 | Financials | 6.97% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ACG
26
DELISTED
AllianceBernstein Income Fund Inc
ACG
| $1.39M | 0.94% |
186,978
+11,357
| +6% | +$87.1K |
2013 Q2
8 quarters
|
|
27
Pfizer
PFE
$161B
| $1.26M | 0.85% |
39,587
+10,830
| +38% | +$353K |
2014 Q2
4 quarters
|
|
28
Automatic Data Processing
ADP
$107B
| $1.25M | 0.84% |
15,572
-65
| -0.4% | -$5.54K |
2013 Q2
8 quarters
|
|
29
Abbott
ABT
$172B
| $1.23M | 0.83% |
25,128
-120
| -0.5% | -$5.76K |
2013 Q2
8 quarters
|
|
30
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.7B
| $1.23M | 0.83% |
153,887
-35,900
| -19% | -$294K |
2013 Q2
8 quarters
|
|
|
MCR
31
DELISTED
MFS Charter Income Trust
MCR
| $1.22M | 0.82% |
143,877
+11,453
| +9% | +$101K |
2014 Q3
3 quarters
|
|
32
Special Opportunities Fund
SPE
$139M
| $1.16M | 0.78% |
79,452
+15,174
| +24% | +$224K |
2013 Q2
8 quarters
|
|
33
Virtus Total Return Fund
ZTR
$309M
| $1.13M | 0.76% |
87,570
-81
| -0.1% | -$1.09K |
2013 Q2
8 quarters
|
|
|
34
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.7B
| $1.12M | 0.75% |
4,088
-3,685
| -47% | -$1.02M |
2013 Q2
8 quarters
|
|
35
TCW Strategic Income Fund
TSI
$271M
| $1.09M | 0.74% |
212,576
+33,785
| +19% | +$182K |
2014 Q1
5 quarters
|
|
36
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$555M
| $1.02M | 0.68% |
94,096
+16,821
| +22% | +$183K |
2013 Q2
8 quarters
|
|
37
Eaton Vance Limited Duration Income Fund
EVV
$981M
| $763K | 0.51% |
56,667
+14,602
| +35% | +$208K |
2014 Q4
2 quarters
|
|
38
Merck
MRK
$359B
| $747K | 0.5% |
13,751
-1,960
| -12% | -$110K |
2013 Q2
8 quarters
|
|
|
MIN
39
Aberdeen Intermediate Income Fund
MIN
$261M
| $720K | 0.48% |
25,957
| – | – |
2013 Q4
6 quarters
|
|
40
JPMorgan Chase
JPM
$885B
| $665K | 0.45% |
9,815
-1,235
| -11% | -$80.6K |
2013 Q2
8 quarters
|
|
41
Eaton Vance Short Duration Diversified Income Fund
EVG
$139M
| $656K | 0.44% |
47,383
| – | – |
2014 Q2
4 quarters
|
|
42
GSK
GSK
$93.2B
| $647K | 0.44% |
12,432
| – | – |
2013 Q2
8 quarters
|
|
|
43
Royce Value Trust
RVT
$2.11B
| $619K | 0.42% |
44,887
-38,516
| -46% | -$548K |
2013 Q2
8 quarters
|
|
44
iShares Core US Aggregate Bond ETF
AGG
$137B
| $618K | 0.42% |
5,685
+185
| +3% | +$20.3K |
2013 Q2
8 quarters
|
|
45
Enterprise Products Partners
EPD
$77.9B
| $614K | 0.41% |
20,540
-1,320
| -6% | -$43.2K |
2013 Q2
8 quarters
|
|
46
Novartis
NVS
$273B
| $607K | 0.41% |
6,883
-3,189
| -32% | -$293K |
2013 Q2
8 quarters
|
|
47
DELISTED
Du Pont De Nemours E I
DD
| $605K | 0.41% |
9,960
-3,512
| -26% | -$237K |
2013 Q2
8 quarters
|
|
48
Bank of America
BAC
$380B
| $580K | 0.39% |
34,087
+9,151
| +37% | +$151K |
2014 Q4
2 quarters
|
|
49
Berkshire Hathaway Class B
BRK.B
$1.1T
| $560K | 0.38% |
4,115
+215
| +6% | +$30.7K |
2013 Q2
8 quarters
|
|
|
50
Eli Lilly
LLY
$1.05T
| $536K | 0.36% |
+6,420
| New | +$489K |
2015 Q2
0 quarters
|
|
Similar funds
AZA
CCM
MIM
YCM
GCM
HIM
MIS
CL
Independence Trust's Q2 2015 Portfolio in Review
As of Q2 2015, Independence Trust held 132 positions worth $148M, down 6% from $158M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Independence Trust's Q2 2015 filing shows 11 new, 28 increased, 43 reduced and 13 closed positions. Its largest new stake was NUVEEN SENIOR INCM FD: 77,037 shares worth $493K. The largest sale was State Street SPDR S&P MIDCAP 400 ETF Trust, an estimated $1.02M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 51% a quarter earlier, followed by Healthcare and Industrials.
- Independence Trust's largest Q2 2015 buy was NUVEEN SENIOR INCM FD: 77,037 shares worth $493K.
- Independence Trust added most to Boeing in Q2 2015, an estimated $2.28M increase.
- Independence Trust's biggest Q2 2015 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $1.02M.
- Independence Trust fully exited Reynolds American Inc in Q2 2015, selling an estimated $602K.
- Independence Trust's ten largest holdings make up 50% of its $148M portfolio in Q2 2015.
- Independence Trust opened 11 new positions and closed 13 in Q2 2015.
- Independence Trust's portfolio value fell 6% quarter-over-quarter to $148M.
Based on Independence Trust's 13F filing for Q2 2015, filed 13 Jul 2015.